View Archive »
About The Cover
The cover for issue 45 of Oncotarget features Figure 2A-2C, "Manhattan plot for candidate RNA editing SNPs among a) endometrioid cases (n = 1,439) versus controls (n = 21,693), b) mucinous cases (n = 696) versus controls, and c) clear cell cases (n = 660) versus controls," from Permuth, et al.
|
|
Table of Contents
Priority Research Papers
|
| Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a largescale collaboration |
|
https://doi.org/10.18632/oncotarget.10546
|
| 72381-72394 |
|
| Multifocal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer |
|
https://doi.org/10.18632/oncotarget.11718
|
| 72395-72414 |
|
| The mitochondrial translation machinery as a therapeutic target in Mycdriven lymphomas |
|
https://doi.org/10.18632/oncotarget.11719
|
| 72415-72430 |
Research Papers: Gerotarget (Focus on Aging)
|
| PROX1 is a novel pathwayspecific prognostic biomarker for highgrade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status |
|
https://doi.org/10.18632/oncotarget.11957
|
| 72431-72442 |
|
| A small molecule inhibitor of PAI1 protects against doxorubicininduced cellular senescence |
|
https://doi.org/10.18632/oncotarget.12494
|
| 72443-72457 |
|
| Baicalein protects against oxLDLcaused oxidative stress and inflammation by modulation of AMPK alpha |
|
https://doi.org/10.18632/oncotarget.12788
|
| 72458-72468 |
Research Papers: Pathology
|
| Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer’s disease |
|
https://doi.org/10.18632/oncotarget.12505
|
| 72469-72474 |
|
| Tolllike 4 receptor /NFκB inflammatory/miR146a pathway contributes to the ARTcorrelated preterm birth outcome |
|
https://doi.org/10.18632/oncotarget.11987
|
| 72475-72485 |
|
| RNA binding protein tristetraprolin in a murine model of recurrent pregnancy loss |
|
https://doi.org/10.18632/oncotarget.12539
|
| 72486-72502 |
|
| Wogonin prevents TLR4NFκBmedicated neuroinflammation and improves retinal ganglion cells survival in retina after optic nerve crush |
|
https://doi.org/10.18632/oncotarget.12700
|
| 72503-72517 |
Research Papers: Immunology
|
| Proteomic analysis uncovers common effects of IFNγ and IL27 on the HLA class I antigen presentation machinery in human cancer cells |
|
https://doi.org/10.18632/oncotarget.12235
|
| 72518-72536 |
|
| Umbilical cordderived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a coculture – a preliminary study |
|
https://doi.org/10.18632/oncotarget.12345
|
| 72537-72545 |
|
| A long noncoding RNA positively regulates CD56 in human natural killer cells |
|
https://doi.org/10.18632/oncotarget.12466
|
| 72546-72558 |
|
| Generation of infectious RNA complexes in orbiviruses: RNARNA interactions of genomic segments |
|
https://doi.org/10.18632/oncotarget.12496
|
| 72559-72570 |
Research Papers: Chromosome
|
| ZSCAN5B and primatespecific paralogs bind RNA polymerase III genes and extraTFIIIC ETC sites to modulate mitotic progression |
|
https://doi.org/10.18632/oncotarget.12508
|
| 72571-72592 |
Research Papers
|
| Identification of miR30b3p and miR30d5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening |
|
https://doi.org/10.18632/oncotarget.12241
|
| 72593-72607 |
|
| Janus and PI3kinases mediate glucocorticoid resistance in activated chronic leukemia cells |
|
https://doi.org/10.18632/oncotarget.11618
|
| 72608-72621 |
|
| Tumor and circulating biomarkers in patients with secondline hepatocellular carcinoma from the randomized phase II study with tivantinib |
|
https://doi.org/10.18632/oncotarget.11621
|
| 72622-72633 |
|
| Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug classdependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L |
|
https://doi.org/10.18632/oncotarget.12055
|
| 72634-72653 |
|
| Biomarker analysis of the MITO2 phase III trial of firstline treatment in ovarian cancer: predictive value of DNAPK and phosphorylated ACC |
|
https://doi.org/10.18632/oncotarget.12056
|
| 72654-72661 |
|
| IMP1 an mRNA binding protein that reduces the metastatic potential of breast cancer in a mouse model |
|
https://doi.org/10.18632/oncotarget.12083
|
| 72662-72671 |
|
| Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a metaanalysis |
|
https://doi.org/10.18632/oncotarget.12183
|
| 72672-72684 |
|
| Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality |
|
https://doi.org/10.18632/oncotarget.12234
|
| 72685-72698 |
|
| Interaction of microtubules with the actin cytoskeleton via crosstalk of EB1containing +TIPs and γactin in epithelial cells |
|
https://doi.org/10.18632/oncotarget.12236
|
| 72699-72715 |
|
| Regulation of tumor growth by circulating fulllength chromogranin A |
|
https://doi.org/10.18632/oncotarget.12237
|
| 72716-72732 |
|
| Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.12238
|
| 72733-72745 |
|
| MicroRNA26b attenuates monocrotalineinduced pulmonary vascular remodeling via targeting connective tissue growth factor CTGF and cyclin D1 CCND1 |
|
https://doi.org/10.18632/oncotarget.10125
|
| 72746-72757 |
|
| Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP9 pathways in bladder cancer |
|
https://doi.org/10.18632/oncotarget.11805
|
| 72758-72766 |
|
| Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer |
|
https://doi.org/10.18632/oncotarget.11889
|
| 72767-72776 |
|
| cAbl inhibits breast cancer tumorigenesis through reactivation of p53mediated p21 expression |
|
https://doi.org/10.18632/oncotarget.11909
|
| 72777-72794 |
|
| DRG1 is a potential oncogene in lung adenocarcinoma and promotes tumor progression via spindle checkpoint signaling regulation |
|
https://doi.org/10.18632/oncotarget.11973
|
| 72795-72806 |
|
| SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer |
|
https://doi.org/10.18632/oncotarget.12020
|
| 72807-72818 |
|
| Prognostic role and correlation of CA9 CD31 CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.12022
|
| 72819-72832 |
|
| Long noncoding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and CIAP1 complexes to activating PI3KAKT pathway |
|
https://doi.org/10.18632/oncotarget.12023
|
| 72833-72844 |
|
| Aberrant expression of JNKassociated leucinezipper protein JLP promotes accelerated growth of ovarian cancer |
|
https://doi.org/10.18632/oncotarget.12069
|
| 72845-72859 |
|
| Comprehensive adipocytic and neurogenic tissue microarray analysis of NYESO1 expression a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma |
|
https://doi.org/10.18632/oncotarget.12096
|
| 72860-72867 |
|
| Antitumor activity of a novel antivascular endothelial growth factor receptor1 monoclonal antibody that does not interfere with ligand binding |
|
https://doi.org/10.18632/oncotarget.12108
|
| 72868-72885 |
|
| Synergistic activity of ALK and mTOR inhibitors for the treatment of NPMALK positive lymphoma |
|
https://doi.org/10.18632/oncotarget.12128
|
| 72886-72897 |
|
| Prognostic role of the lymph node ratio in node positive colorectal cancer: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.12131
|
| 72898-72907 |
|
| Genomic characterization of liver metastases from colorectal cancer patients |
|
https://doi.org/10.18632/oncotarget.12140
|
| 72908-72922 |
|
| Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immunestimulating activity on peripheral blood immune cells |
|
https://doi.org/10.18632/oncotarget.12141
|
| 72923-72940 |
|
| Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway |
|
https://doi.org/10.18632/oncotarget.12146
|
| 72941-72960 |
|
| PD1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma |
|
https://doi.org/10.18632/oncotarget.12150
|
| 72961-72977 |
|
| Multicycle chemotherapy with the glycolipidlike polymeric micelles evade cancer stem cell enrichment in breast cancer therapy |
|
https://doi.org/10.18632/oncotarget.12159
|
| 72978-72989 |
|
| Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROSmediated regulation of the PTEN/PI3K/Akt pathway |
|
https://doi.org/10.18632/oncotarget.12166
|
| 72990-73002 |
|
| Elevated level of Interleukin35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3 |
|
https://doi.org/10.18632/oncotarget.12193
|
| 73003-73015 |
|
| Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and Src activity using an active component of Antrodia cinnamomea mycelia |
|
https://doi.org/10.18632/oncotarget.12194
|
| 73016-73031 |
|
| Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKKβ/IκBα/NFκB axis |
|
https://doi.org/10.18632/oncotarget.12195
|
| 73032-73044 |
|
| Tumour suppressor gene CDKNA2 status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer |
|
https://doi.org/10.18632/oncotarget.12196
|
| 73045-73054 |
|
| The Cterminal domain of connexin43 modulates cartilage structure via chondrocyte phenotypic changes |
|
https://doi.org/10.18632/oncotarget.12197
|
| 73055-73067 |
|
| The efficacy and safety of antiPD1/PDL1 antibodies for treatment of advanced or refractory cancers: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.12230
|
| 73068-73079 |
|
| Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways |
|
https://doi.org/10.18632/oncotarget.11485
|
| 73080-73100 |
|
| The role of SH3GL3 in myeloma cell migration/invasion stemness and chemoresistance |
|
https://doi.org/10.18632/oncotarget.12231
|
| 73101-73113 |
|
| A novel codrug of aspirin and ursolic acid interrupts adhesion invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFRmediated signaling pathways: multiple targets for cancer metastasis prevention and treatment |
|
https://doi.org/10.18632/oncotarget.12232
|
| 73114-73129 |
|
| Intraglomerular crosstalk elaborately regulates podocyte injury and repair in diabetic patients: insights from a 3D multiscale modeling study |
|
https://doi.org/10.18632/oncotarget.12233
|
| 73130-73146 |
|
| Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response |
|
https://doi.org/10.18632/oncotarget.12246
|
| 73147-73159 |
|
| Cyr61positive cancer stemlike cells enhances distal metastases of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.12248
|
| 73160-73170 |
|
| Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor TP in prostate cancer: clinical significance and diagnostic potential |
|
https://doi.org/10.18632/oncotarget.12256
|
| 73171-73187 |
|
| MiR128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the cmet/PI3K/AKT pathway |
|
https://doi.org/10.18632/oncotarget.12283
|
| 73188-73199 |
|
| Casespecific potentiation of glioblastoma drugs by pterostilbene |
|
https://doi.org/10.18632/oncotarget.12298
|
| 73200-73215 |
|
| ADH1B and CDH1 polymorphisms predict prognosis in male patients with nonmetastatic laryngeal cancer |
|
https://doi.org/10.18632/oncotarget.12301
|
| 73216-73228 |
|
| Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin Bmediated Nlrp3 inflammasome activation |
|
https://doi.org/10.18632/oncotarget.12302
|
| 73229-73241 |
|
| Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP9 through activation of AP1 and NFκB in esophageal squamous cell carcinoma cells |
|
https://doi.org/10.18632/oncotarget.12303
|
| 73242-73256 |
|
| An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.12304
|
| 73257-73269 |
|
| Low carbohydrate diet prevents Mcl1mediated resistance to BH3mimetics |
|
https://doi.org/10.18632/oncotarget.12309
|
| 73270-73279 |
|
| Thermosensitive composite hydrogels based on poloxamer 407 and alginate and their therapeutic effect in embolization in rabbit VX2 liver tumors |
|
https://doi.org/10.18632/oncotarget.11789
|
| 73280-73291 |
|
| Coapplication of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability |
|
https://doi.org/10.18632/oncotarget.12320
|
| 73292-73308 |
|
| Keratin 18deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitisassociated liver carcinogenesis |
|
https://doi.org/10.18632/oncotarget.12325
|
| 73309-73322 |
|
| p53 in the mitochondria as a transacting protein provides errorcorrection activities during the incorporation of noncanonical dUTP into DNA |
|
https://doi.org/10.18632/oncotarget.12331
|
| 73323-73336 |
|
| ERBB2 mutations associated with solid variant of highgrade invasive lobular breast carcinomas |
|
https://doi.org/10.18632/oncotarget.11819
|
| 73337-73346 |
|
| Promoter methylation patterns of ABCB1 ABCC1 and ABCG2 in human cancer cell lines multidrugresistant cell models and tumor tumoradjacent and tumordistant tissues from breast cancer patients |
|
https://doi.org/10.18632/oncotarget.12332
|
| 73347-73369 |
|
| CARP1 functional mimetics are novel inhibitors of drugresistant triple negative breast cancers |
|
https://doi.org/10.18632/oncotarget.12333
|
| 73370-73388 |
|
| LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors |
|
https://doi.org/10.18632/oncotarget.12334
|
| 73389-73401 |
|
| Asporin enhances colorectal cancer metastasis through activating the EGFR/Src/cortactin signaling pathway |
|
https://doi.org/10.18632/oncotarget.12336
|
| 73402-73413 |
|
| Reciprocal regulation of the cholinic phenotype and epithelialmesenchymal transition in glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.12337
|
| 73414-73431 |
|
| Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice |
|
https://doi.org/10.18632/oncotarget.12369
|
| 73432-73447 |
|
| Lowdose salinomycin induces antileukemic responses in AML and MLL |
|
https://doi.org/10.18632/oncotarget.11866
|
| 73448-73461 |
|
| GPR30 disrupts the balance of GABAergic and glutamatergic transmission in the spinal cord driving to the development of bone cancer pain |
|
https://doi.org/10.18632/oncotarget.11867
|
| 73462-73472 |
|
| Recombinant human bone morphogenetic protein2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via cMyc with aurora kinases |
|
https://doi.org/10.18632/oncotarget.11969
|
| 73473-73485 |
|
| Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer |
|
https://doi.org/10.18632/oncotarget.11970
|
| 73486-73496 |
|
| Piperlongumine induces apoptosis and reduces bortezomib resistance by inhibiting STAT3 in multiple myeloma cells |
|
https://doi.org/10.18632/oncotarget.11988
|
| 73497-73508 |
|
| Integrating microRNA and mRNA expression profiles of acute promyelocytic leukemia cells to explore the occurrence mechanisms of differentiation syndrome |
|
https://doi.org/10.18632/oncotarget.11989
|
| 73509-73524 |
|
| Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation |
|
https://doi.org/10.18632/oncotarget.12321
|
| 73525-73540 |
|
| Identification of long noncoding RNAs biomarkers for early diagnosis of myocardial infarction from the dysregulated codingnoncoding coexpression network |
|
https://doi.org/10.18632/oncotarget.11999
|
| 73541-73551 |
|
| Matrix metalloproteinase13 refines pathological staging of precancerous colorectal lesions |
|
https://doi.org/10.18632/oncotarget.12429
|
| 73552-73557 |
|
| CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.12434
|
| 73558-73572 |
|
| Flavan3ols consumption and cancer risk: a metaanalysis of epidemiologic studies |
|
https://doi.org/10.18632/oncotarget.12017
|
| 73573-73592 |
|
| NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction |
|
https://doi.org/10.18632/oncotarget.12435
|
| 73593-73606 |
|
| Chicken GHR natural antisense transcript regulates GHR mRNA in LMH cells |
|
https://doi.org/10.18632/oncotarget.12437
|
| 73607-73617 |
|
| AntiEGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.12037
|
| 73618-73637 |
|
| Decreased expression of IDH1R132H correlates with poor survival in gastrointestinal cancer |
|
https://doi.org/10.18632/oncotarget.12039
|
| 73638-73650 |
|
| Locked nucleic acidinhibitor of miR205 decreases endometrial cancer cells proliferation in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.12043
|
| 73651-73663 |
|
| Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.12046
|
| 73664-73680 |
|
| AsnGlyArgmodified polydopaminecoated nanoparticles for dualtargeting therapy of brain glioma in rats |
|
https://doi.org/10.18632/oncotarget.12047
|
| 73681-73696 |
|
| Secondgeneration proteasome inhibitor carfilzomib enhances doxorubicininduced cytotoxicity and apoptosis in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.12048
|
| 73697-73710 |
|
| Lipopolysaccharide increases the release of VEGFC that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4 NFκB/JNK pathways in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.12449
|
| 73711-73724 |
|
| Role of BCL9L in transforming growth factorβ TGFβinduced epithelialtomesenchymaltransition EMT and metastasis of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.12455
|
| 73725-73738 |
|
| The other face of miR1792a cluster exhibiting tumor suppressor effects in prostate cancer |
|
https://doi.org/10.18632/oncotarget.12061
|
| 73739-73753 |
|
| Bone morphogenetic protein9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population |
|
https://doi.org/10.18632/oncotarget.12062
|
| 73754-73768 |
|
| Unique long noncoding RNA expression signature in ETV6/RUNX1driven Bcell precursor acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.12063
|
| 73769-73780 |
|
| TERT rs2853676 polymorphisms correlate with glioma prognosis in Chinese population |
|
https://doi.org/10.18632/oncotarget.12064
|
| 73781-73791 |
|
| A dosimetric and treatment efficiency evaluation of stereotactic body radiation therapy for peripheral lung cancer using flattening filter free beams |
|
https://doi.org/10.18632/oncotarget.12071
|
| 73792-73799 |
|
| Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer |
|
https://doi.org/10.18632/oncotarget.12070
|
| 73800-73816 |
|
| SHP2 phosphatase as a novel therapeutic target for melanoma treatment |
|
https://doi.org/10.18632/oncotarget.12074
|
| 73817-73829 |
|
| Tetraspecific scFv construct provides NK cell mediated ADCC and selfsustaining stimuli via insertion of IL15 as a crosslinker |
|
https://doi.org/10.18632/oncotarget.12073
|
| 73830-73844 |
|
| CoGAPS matrix factorization algorithm identifies transcriptional changes in AP2alpha target genes in feedback from therapeutic inhibition of the EGFR network |
|
https://doi.org/10.18632/oncotarget.12075
|
| 73845-73864 |
|
| Novel lymph node ratio predicts prognosis of colorectal cancer patients after radical surgery when tumor deposits are counted as positive lymph nodes: a retrospective multicenter study |
|
https://doi.org/10.18632/oncotarget.12076
|
| 73865-73875 |
|
| Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients |
|
https://doi.org/10.18632/oncotarget.12510
|
| 73876-73887 |
|
| miR285p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B |
|
https://doi.org/10.18632/oncotarget.12516
|
| 73888-73902 |
|
| The impact of neuronal Notch1/JNK pathway on intracerebral hemorrhageinduced neuronal injury of rat model |
|
https://doi.org/10.18632/oncotarget.12094
|
| 73903-73911 |
|
| Antibodybased PET of uPA/uPAR signaling with broad applicability for cancer imaging |
|
https://doi.org/10.18632/oncotarget.12528
|
| 73912-73924 |
|
| Transfer of functional microRNAs between glioblastoma and microvascular endothelial cells through gap junctions |
|
https://doi.org/10.18632/oncotarget.12136
|
| 73925-73934 |
|
| A PRISMAcompliant metaanalysis of MDM4 genetic variants and cancer susceptibility |
|
https://doi.org/10.18632/oncotarget.12558
|
| 73935-73944 |
|
| A comprehensive metaanalysis of genetic associations between five key SNPs and colorectal cancer risk |
|
https://doi.org/10.18632/oncotarget.12154
|
| 73945-73959 |
|
| The tumorassociated antigen RHAMM HMMR/CD168 is expressed by monocytederived dendritic cells and presented to T cells |
|
https://doi.org/10.18632/oncotarget.12170
|
| 73960-73970 |
|
| Identification of a five B cellassociated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference |
|
https://doi.org/10.18632/oncotarget.12605
|
| 73971-73983 |
|
| Circulating vascular endothelial growth factor VEGF as predictive factor of progressionfree survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group GSF/GETO |
|
https://doi.org/10.18632/oncotarget.12172
|
| 73984-73994 |
|
| Generation of affibody molecules specific for HPV16 E7 recognition |
|
https://doi.org/10.18632/oncotarget.12174
|
| 73995-74005 |
|
| Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer |
|
https://doi.org/10.18632/oncotarget.12176
|
| 74006-74014 |
|
| FGF4 induces epithelialmesenchymal transition by inducing storeoperated calcium entry in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.12187
|
| 74015-74030 |
|
| Classifying lower grade glioma cases according to whole genome gene expression |
|
https://doi.org/10.18632/oncotarget.12188
|
| 74031-74042 |
|
| Impact of HuR inhibition by the small molecule MS444 on colorectal cancer cell tumorigenesis |
|
https://doi.org/10.18632/oncotarget.12189
|
| 74043-74058 |
|
| MicroRNA98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4 |
|
https://doi.org/10.18632/oncotarget.12190
|
| 74059-74073 |
|
| Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy |
|
https://doi.org/10.18632/oncotarget.12615
|
| 74074-74081 |
|
| Variable but consistent pattern of Meningioma 1 gene MN1 expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection |
|
https://doi.org/10.18632/oncotarget.12269
|
| 74082-74096 |
|
| Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers |
|
https://doi.org/10.18632/oncotarget.12272
|
| 74097-74106 |
|
| Immune adjuvant effect of a Toxoplasma gondii profilinlike protein in autologous wholetumorcell vaccination in mice |
|
https://doi.org/10.18632/oncotarget.12316
|
| 74107-74119 |
|
| Exploring timing activation of functional pathway based on differential coexpression analysis in preimplantation embryogenesis |
|
https://doi.org/10.18632/oncotarget.12339
|
| 74120-74131 |
|
| Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROSactivated GCN2eIF2αATF4xCT pathway |
|
https://doi.org/10.18632/oncotarget.12356
|
| 74132-74151 |
|
| Cytomorphological characteristics of glassy cell carcinoma of the uterine cervix: histopathological correlation and human papillomavirus genotyping |
|
https://doi.org/10.18632/oncotarget.12361
|
| 74152-74161 |
|
| Advanced lung adenocarcinomas with ROS1rearrangement frequently show hepatoid cell |
|
https://doi.org/10.18632/oncotarget.12364
|
| 74162-74170 |
|
| Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy |
|
https://doi.org/10.18632/oncotarget.12367
|
| 74171-74188 |
|
| Prostatespecific membrane antigen PSMA assembles a macromolecular complex regulating growth and survival of prostate cancer cells “in vitro†and correlating with progression “in vivo†|
|
https://doi.org/10.18632/oncotarget.12404
|
| 74189-74202 |
|
| Low pH impairs complementdependent cytotoxicity against IgGcoated target cells |
|
https://doi.org/10.18632/oncotarget.12412
|
| 74203-74216 |
|
| MicroRNA126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3KAKT signal pathway |
|
https://doi.org/10.18632/oncotarget.12487
|
| 74217-74226 |
|
| Germline mutations in Japanese familial pancreatic cancer patients |
|
https://doi.org/10.18632/oncotarget.12490
|
| 74227-74235 |
|
| Overexpression and potential roles of NRIP1 in psoriasis |
|
https://doi.org/10.18632/oncotarget.12371
|
| 74236-74246 |
|
| Endotoxin promotes neutrophil hierarchical chemotaxis via the p38membrane receptor pathway |
|
https://doi.org/10.18632/oncotarget.12093
|
| 74247-74258 |
|
| A nextgeneration bifunctional photosensitizer with improved watersolubility for photodynamic therapy and diagnosis |
|
https://doi.org/10.18632/oncotarget.12366
|
| 74259-74268 |
|
| Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy |
|
https://doi.org/10.18632/oncotarget.12368
|
| 74269-74285 |
Clinical Research Papers
|
| Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.10951
|
| 74286-74302 |
|
| Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.11030
|
| 74303-74313 |
|
| Preoperative neutrophiltolymphocyte ratio and tumorrelated factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma PDAC |
|
https://doi.org/10.18632/oncotarget.11031
|
| 74314-74324 |
|
| LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.11101
|
| 74325-74336 |
|
| Lymph node ratiobased staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection |
|
https://doi.org/10.18632/oncotarget.11188
|
| 74337-74349 |
Reviews
|
| The efficacy and potential predictive factors of PD1/PDL1 blockades in epithelial carcinoma patients: a systematic review and meta analysis |
|
https://doi.org/10.18632/oncotarget.11291
|
| 74350-74361 |
|
| Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.11413
|
| 74362-74379 |
|
| Discovery and clinical introduction of firstinclass imipridone ONC201 |
|
https://doi.org/10.18632/oncotarget.11814
|
| 74380-74392 |
|
| ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system |
|
https://doi.org/10.18632/oncotarget.11911
|
| 74393-74409 |
Case Reports
|
| Young patient with arterial thrombosis and skin changes as the onset manifestations: POEMS syndrome |
|
https://doi.org/10.18632/oncotarget.12570
|
| 74410-74414 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
